mi-eye 3 needlescope with cannula, mi-tablet 3— 510(k) K212556

Name: FDA 510(k) clearance K212556
Creator: U.S. Food and Drug Administration
Published: 2021-09-15

Substantially Equivalent

Trice Medical, Inc.

FDA 510(k) clearance K212556 for mi-eye 3 needlescope with cannula, mi-tablet 3, Substantially Equivalent on 2021-09-15. Applicant: Trice Medical, Inc.. Device class: 2.

Clearance details

Applicant: Trice Medical, Inc.
Product code: Code HRX
Device class: Class 2
Regulation: 21 CFR 888.1100
Advisory panel: Orthopedic
Date received: 2021-08-13
Decision date: 2021-09-15
Decision: Substantially Equivalent
Clearance type: Special
Location: Malvern, PA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code HRX

view all

K260203 — Fule Vertebroplasty Balloon Catheter2026-08-28
K254103 — HOPKINS Telescopes for Arthroscopy2026-08-26
K252790 — Digital ClarusScope System and Digital NeuroPEN System2026-05-26
K253523 — Freedom DS Decompression System2026-04-16
K252546 — VantageTM Lumbar Decompression Kit2026-03-12

More clearances from Trice Medical, Inc.

view all

K241700 — Tenex 2nd Generation System2024-11-18
K141119 — CAMERA ENABLED PROBE2014-07-29

Adverse events under product code HRX

product code HRX

Injury: 623
Malfunction: 11,257
Total: 11,880

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.